CLINICAL_TRIALS
trial_result
· 2019-11-19
Clinical Trial Update: A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Summary
Phase 3 trial update for ixekizumab in biologic DMARD-naive participants with radiographic axial spondyloarthritis has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-11-19